truCan Ultra CIV

Canine Influenza Vaccine

H3N2 & H3N8

Killed Virus

For use in animals only

This product has been shown to be effective for the vaccination of healthy dogs, 7 weeks of age and older, against disease caused by Canine Influenza Virus (CIV). The duration of immunity for this product has not been determined. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

The CIV strains contained in this product are:

● H3N2 Strain A/Ca/IN/001177/17

● H3N8 Strain A/Ca/MA/026810/16

Dose: Inject one 0.5 mL dose subcutaneously using aseptic technique. The presence of maternal antibody is known to interfere with the development of active immunity in dogs and additional boosters will be required in most young animals. All dogs should initially receive one dose of this product and a second dose 2 to 3 weeks later. The need for annual booster vaccinations has not been established for this product. For advice on revaccination frequency and annual booster vaccinations, consultation with a veterinarian is recommended.

truCan Ultra CIV Caution

Store in the dark at 2° to 8°C (35° to 46°F). AVOID FREEZING. SHAKE WELL. Do not mix with other products, except as specified on the label. This product has not been tested in pregnant animals. In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician.

Gentamicin and Amphotericin B added as preservatives.

truCan Ultra CIV Caution

In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package.

Elanco US Inc., Fort Dodge, IA 50501

Phone: 888-545-5973

VLN/PCN 196/15Q5.20

TruCan, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

© 2022 Elanco or its affiliates.

25 Doses

25 x 0.5 mL Vials of Vaccine

YL103575A W1

CPN: 1943043.0